Back to top
more

Alcon (ALC)

(Delayed Data from NYSE)

$85.75 USD

85.75
877,048

+0.30 (0.35%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $85.74 -0.01 (-0.01%) 5:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (145 out of 244)

Industry: Medical - Instruments

Zacks News

Zacks Equity Research

Alcon (ALC) Q3 Earnings Surpass Estimates, Sales Guidance Cut

Alcon's (ALC) robust innovation pipeline is delivering solid results as evidenced by the strength in its comprehensive portfolio of PCIOLs, including PanOptix and Vivity.

Zacks Equity Research

Alcon (ALC) Clareon Suite to Get a Boost With Product Launch

With the latest launch of Clareon Toric, Alcon's (ALC) Clareon Collection of IOLs is complete in the United States.

    Zacks Equity Research

    Alcon (ALC) Faces Cost Pressure, Supply Chain Disruption

    Given the supply chain challenges, unfavorable foreign exchange impact and inflationary pressure, Alcon (ALC) reduces its core EPS and net sales expectations for 2022.

    Zacks Equity Research

    Aerie (AERI) Rallies 205.6% in the Past Three Months: Here's Why

    Aerie (AERI) shares have skyrocketed in the past three months after the company announced its definitive agreement with Alcon, wherein the latter will acquire the former for $770 million.

    Zacks Equity Research

    Aerie (AERI) to be Acquired by Alcon for $770M, Shares Up

    Aerie (AERI) enters into an agreement with Alcon to be acquired for $770 million. Shares gain.

    Zacks Equity Research

    Alcon (ALC) Q2 Earnings Surpass Estimates, Guidance Lowered

    Alcon's (ALC) robust innovation pipeline is delivering solid results as evidenced by the successful launch of new ATIOL roles and SiHy contact lenses.

    Zacks Equity Research

    Cigna (CI) to Announce Q2 Earnings: Here's What to Expect

    Cigna's (CI) second-quarter results are likely to reflect higher pharmacy revenues and a growing customer base.

    Zacks Equity Research

    DraftKings (DKNG) to Report Q2 Earnings: What's in Store?

    DraftKings' (DKNG) second-quarter 2022 performance is likely to have benefited from the robust demand for mobile sports betting and expansion efforts in new states.

    Zacks Equity Research

    What Awaits Warner Bros. Discovery (WBD) in Q2 Earnings?

    Warner Bros. Discovery's (WBD) Q2 results are expected to reflect benefits from a solid content portfolio and slow yet steady advertising revenues.

    Zacks Equity Research

    NortonLifeLock (NLOK) to Report Q1 Earnings: What's in Store?

    Though the heightened IT security demand amid the hybrid work environment is likely to have benefited NortonLifeLock's (NLOK) Q1 performance, forex headwinds might have hurt sales and earnings growth.

    Zacks Equity Research

    CVS Health (CVS) to Report Q2 Earnings: What's in the Cards?

    Robust retail and pharmacy sales performance are likely to have driven CVS Health's (CVS) Q2 performance.

    Zacks Equity Research

    Cumulus Media (CMLS) to Report Q2 Earnings: What's in Store?

    Cumulus Media's (CMLS) Q2 performance is expected to have been aided by growth in digital business and demand for podcasting content amid tepid demand for advertising solutions.

    Zacks Equity Research

    Paramount Global (PARA) to Report Q2 Earnings: What's in Store?

    Paramount Global's (PARA) Q2 performance is expected to have been aided by growth in viewership, driven by strength in streaming services, including Paramount+ amid tepid advertiser demand.

    Zacks Equity Research

    Factors to Note Ahead of Atlassian's (TEAM) Q4 Earnings

    Atlassian's (TEAM) Q4 results are likely to reflect the rising demand for cloud solutions and the massive digitalization of work by organizations.

    Zacks Equity Research

    Twilio (TWLO) to Report Q2 Earnings: What's in the Offing?

    Twilio's (TWLO) Q2 revenues are expected to have benefited from the accelerated digital transformation and recent acquisitions, while the elevated spending on product and market expansions might have weighed on earnings.

    Zacks Equity Research

    What's in the Offing for Amdocs (DOX) This Earnings Season?

    The increased demand for its cloud-managed services and continuous deal wins from major telecom companies are likely to have aided Amdocs' (DOX) third-quarter performance.

    Zacks Equity Research

    What's in the Offing for Cloudflare (NET) This Earnings Season?

    Cloudflare's (NET) Q2 performance is likely to have witnessed the solid demand for security solutions and the benefits of its recurring subscription-based business model and diversified customer base.

    Zacks Equity Research

    Electronic Arts (EA) to Report Q1 Earnings: What's in Store?

    Electronic Arts' (EA) first-quarter fiscal 2023 results are expected to reflect steady demand for its digital and live services. However, the lack of major game releases might have dented profits.

    Zacks Equity Research

    Match Group (MTCH) to Post Q2 Earnings: What's in Store?

    Match Group's (MTCH) second-quarter 2022 earnings are expected to have benefited from the continued momentum in Tinder and solid performances of other apps like Hinge, Plenty Of Fish and OkCupid.

    Zacks Equity Research

    Fortinet (FTNT) to Post Q2 Earnings: What's in the Cards?

    Fortinet's (FTNT) second-quarter results are likely to reflect benefits from increased demand for IT security along with the strong adoption of its Fortinet Security Fabric, cloud and SD-WAN offerings.

    Zacks Equity Research

    DXC Technology (DXC) to Post Q1 Earnings: What's in Store?

    DXC Technology's (DXC) first-quarter fiscal 2023 performance is likely to have been negatively impacted by the business operation closure in Russia, the strong U.S. dollar and divestitures.

    Zacks Equity Research

    Paycom (PAYC) to Post Q2 Earnings: What's in the Cards?

    Paycom's (PAYC) Q2 results are likely to have benefited from new client additions, business wins & market share gains. However, pandemic disruptions might impact its client headcount.

    Zacks Equity Research

    Neogen (NEOG) Q4 Earnings Top Estimates, Gross Margin Up

    Neogen (NEOG) delivers better-than-expected results for the fiscal fourth quarter, with robust segmental performance driving the top line.

    Zacks Equity Research

    Henry Schein (HSIC) to Report Q2 Earnings: What's in Store?

    Henry Schein's (HSIC) Q2 performance will likely reflect continued strength in its dental and medical businesses.

    Zacks Equity Research

    IDEXX (IDXX) to Report Q2 Earnings: What's in the Cards?

    IDEXX's (IDXX) Q2 performance will likely benefit from strong sales from the CAG Diagnostics and Water businesses.